Donald Trump has hinted at a tariff reprieve for pharmaceutical companies, which are braced for fresh sector-specific import taxes as early as next week.
He reiterated at a meeting of pharma, tech and industry bosses in the White House that if companies moved their operations to plants in the US they would face no tariffs, but he suggested that they would get “a lot of time” to make the switch before facing levies.
